Juan Paramo, MD
Surgical Oncology · Miami Beach, FLNPI 1790715365
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,602 of the $2,993 with a category attached, or 86.9%. It is spread thinly across 24 manufacturers, the largest accounting for just 15.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $923 and has fallen 98.3% since, to $15 in 2025.
Across 52 payments — averaging $57.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Elucent Medical$458
- Molli Surgical (US) Inc$343
- Endomagnetics Ltd$310
- Hologic Sales And Service, LLC$288
- Genentech USA, Inc.$202
- Sirtex Medical Inc$165
- plus $1K from 18 others
Across 12 payments — averaging $16,542 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- E.r. Squibb & Sons, L.L.C.$179K
- Amgen$16K
- Genentech, Inc.$3K
What the payments were for
- Travel & lodging$39213%
- Food & beverage$2,60287%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Elucent Medical | 2 | $458 |
| Molli Surgical (US) Inc | 2 | $343 |
| Endomagnetics Ltd | 3 | $310 |
| Hologic Sales And Service, LLC | 3 | $288 |
| Genentech USA, Inc. | 7 | $202 |
| Sirtex Medical Inc | 1 | $165 |
| Dilon Technologies, Inc. | 2 | $148 |
| Myriad Genetic Laboratories, Inc. | 1 | $125 |
| Leica Microsystems Inc. | 1 | $119 |
| Covidien LP | 1 | $106 |
| C2dx, Inc | 1 | $101 |
| Novartis | 5 | $100 |
| Cardinal Health 414 LLC | 1 | $91 |
| AbbVie(2 entities) | 4 | $73 |
| Integra Lifesciences Corporation | 2 | $69 |
| Amgen | 4 | $69 |
| Foundation Medicine, Inc. | 3 | $64 |
| Merck | 2 | $37 |
| Johnson & Johnson | 2 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Pfizer | 1 | $21 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| EUSA Pharma (US) LLC | 1 | $17 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Magseed$300
- Magtrace$300
- SIR-Spheres Microspheres$165
- TRIDENT SPECIMEN RADIOGRAPHY SYSTEM$160
- BioZorb$125
- Localizer$125
- myRisk$125
- HemoBlast Bellows$123
- SENTIMAG$119
- Valleylab$106
How this compares
$2,993 in reported general payments places this provider in the 60th percentile of 133 surgical oncology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levothyroxine Sodium | 62 | $412 |
| Tramadol Hcl | 72 | $148 |
Paid to pharmacies, not to this prescriber.
Other surgical oncology in Miami Beach
- Jessica PastorizaMiami Beach$27K
- Steven HochwaldMiami Beach$12K
- Neha GoelMiami$200K
- Jonathan ZagerTampa$191K
- Horacio AsbunMiami$161K
- Adrian Legaspi SauterHialeah$116K
- Kenneth MeredithSarasota$113K
- Pamela HodulTampa$94K
- Mehran HabibiMiami$73K
- Paul BloomstonFort Myers$68K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.